Heparin for diagnostic trans-radial catheterization

Can we have some randomized data?

Research output: Contribution to journalEditorial

Abstract

Marked heterogeneity exists regarding the dose, time and route of administration of unfractionated heparin for diagnostic trans-radial procedures. In an era of smaller caliber hydrophilic radial sheaths, patent hemostasis technique, and shorter compression times, the utility of heparin to prevent radial artery occlusion remains a question. A randomized clinical trial assessing the utility, timing, dose, and route of administration of unfractionated heparin for diagnostic radial catheterization with an aim to prevent radial artery occlusion is needed.

Original languageEnglish (US)
Pages (from-to)860-861
Number of pages2
JournalCatheterization and Cardiovascular Interventions
Volume92
Issue number5
DOIs
StatePublished - Nov 1 2018

Fingerprint

Catheterization
Heparin
Radial Artery
Hemostasis
Randomized Controlled Trials

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

@article{3f297adafb24419db7324958f52b23f6,
title = "Heparin for diagnostic trans-radial catheterization: Can we have some randomized data?",
abstract = "Marked heterogeneity exists regarding the dose, time and route of administration of unfractionated heparin for diagnostic trans-radial procedures. In an era of smaller caliber hydrophilic radial sheaths, patent hemostasis technique, and shorter compression times, the utility of heparin to prevent radial artery occlusion remains a question. A randomized clinical trial assessing the utility, timing, dose, and route of administration of unfractionated heparin for diagnostic radial catheterization with an aim to prevent radial artery occlusion is needed.",
author = "Harsh Golwala and Joaquin Cigarroa",
year = "2018",
month = "11",
day = "1",
doi = "10.1002/ccd.27937",
language = "English (US)",
volume = "92",
pages = "860--861",
journal = "Catheterization and Cardiovascular Interventions",
issn = "1522-1946",
publisher = "Wiley-Liss Inc.",
number = "5",

}

TY - JOUR

T1 - Heparin for diagnostic trans-radial catheterization

T2 - Can we have some randomized data?

AU - Golwala, Harsh

AU - Cigarroa, Joaquin

PY - 2018/11/1

Y1 - 2018/11/1

N2 - Marked heterogeneity exists regarding the dose, time and route of administration of unfractionated heparin for diagnostic trans-radial procedures. In an era of smaller caliber hydrophilic radial sheaths, patent hemostasis technique, and shorter compression times, the utility of heparin to prevent radial artery occlusion remains a question. A randomized clinical trial assessing the utility, timing, dose, and route of administration of unfractionated heparin for diagnostic radial catheterization with an aim to prevent radial artery occlusion is needed.

AB - Marked heterogeneity exists regarding the dose, time and route of administration of unfractionated heparin for diagnostic trans-radial procedures. In an era of smaller caliber hydrophilic radial sheaths, patent hemostasis technique, and shorter compression times, the utility of heparin to prevent radial artery occlusion remains a question. A randomized clinical trial assessing the utility, timing, dose, and route of administration of unfractionated heparin for diagnostic radial catheterization with an aim to prevent radial artery occlusion is needed.

UR - http://www.scopus.com/inward/record.url?scp=85056713938&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056713938&partnerID=8YFLogxK

U2 - 10.1002/ccd.27937

DO - 10.1002/ccd.27937

M3 - Editorial

VL - 92

SP - 860

EP - 861

JO - Catheterization and Cardiovascular Interventions

JF - Catheterization and Cardiovascular Interventions

SN - 1522-1946

IS - 5

ER -